Healthcare Investor Sam Isaly’s Top Stock Picks Include Pfizer

Page 1 of 2

Sam Isaly’s Orbimed Advisors is a large health care fund investing in companies at various stages from venture capital to the public markets. The fund tends to focus on pharmaceutical and medical device companies as opposed to hospitals and insurers- products, one might say, as opposed to services. This is a strong contrast to most funds’ thesis on healthcare; in fact, only two of Orbimed’s ten largest 13F holdings made our list of the most popular healthcare stocks among hedge funds and one of those- Express Scripts- is a rare services company in Isaly’s portfolio.

The nature of healthcare investments requires Orbimed to take on significant regulatory risks and make sure they are up to date on major announcements and other events which can have an enormous impact on an individual stock’s price. Of course, the fund also has to ensure that its analysts understand the regulatory environment as well as the science behind a company’s product line. Isaly himself has been covering healthcare for over 40 years, roughly half of which has come as an investment manager and half of which came as an analyst for companies such as Chase Manhattan , Merrill Lynch, and Legg Mason.

Orbimed’s grand strategy is to run a portfolio that is more or less balanced between large healthcare companies and smaller-cap companies where the investment team believes that future growth is not being reflected in the current price. When we look at its most recent portfolio, we see a fairly small number of positions worth over $100 million and then a fairly broad range of healthcare stocks. In addition, while there were some large increases or decreases many of Orbimed’s top picks remained the same and we’d assume that most of them are still close to the top of the portfolio. Read on for a brief look at the fund’s five largest holdings or see the full list of stocks it reported owning.

Ken Fisher - FISHER ASSET MANAGEMENT

Isaly and his team owned 8.9 million shares of Pfizer Inc. (NYSE:PFE), making the drug manufacturer its top stock pick. Pfizer’s trailing P/E is 20, though Wall Street analysts expect earnings to be much better this year and so the stock trades at only 11 times consensus earnings for 2013. Revenue and earnings did decline at double-digit rates in the third quarter of 2012 versus a year earlier. Pfizer was also Fisher Asset Management’s favorite stock; that fund is managed by billionaire Ken Fisher (check out Fisher’s stock picks).

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

50 Crazy Facts About Japan You Won’t Believe

Top 10 Least Expensive Hybrid Cars to Save the Planet With

The 10 Biggest ‘Gate’ Controversies in History

The 10 States with the Highest Nursing Shortages Leaving Their Hospitals Depleted

The 10 Best Value Investment Blogs that Every Investor Must Read

The 6 Cheapest Boarding Schools in Europe 2015

The 5 Most Expensive Cars To Insure in the World

The 10 Most Common Genetically Modified Foods

10 Self-Made Billionaires Who Came From Nothing

The 10 Most Expensive Cities to Live in North America

The 13 Most Expensive Headphones in the World to Represent

The Top 20 Wealthiest Soccer Teams in 2014

4 BuzzWorthy Cannabis Stocks And Some Smoking Derivative Plays

The 10 Healthiest Fast Food Chains in America to Dine At

The 5 Most Expensive Cat Food Brands You Can Spoil Your Kitty With

The 6 Best eCommerce Platforms for Small Businesses

The 10 Worst Mistakes an Entrepreneur Can Make

The 5 Most OP Characters in League of Legends to Carry Games and Crush Foes With

The 5 Best Foods to Eat Before Running that Will Help You Pound the Pavement

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

How to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!